HOME >> BIOLOGY >> NEWS
Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics

Palo Alto, Calif June 15, 2004 Though there has been considerable biological and political debate over the use of embryonic stem cells (ESCs) vs. adult stem cells (ASCs) as therapies for tissue engineering and organ transplants, inherent benefits and drawbacks in both techniques compel them to coexist and complement each other.

"On the one hand, it's been very difficult to grow sufficient numbers of ASCs to regenerate tissues or create replacement organs," explains Technical Insights Research Analyst Katherine Austin. "On the other hand, ESCs provoke immune rejection much like any other transplant, and it's also been difficult to grow them in culture without mouse or other animal cells. These obstacles should be overcome in the near future, however."

It is possible to use a procedure called nuclear transplantation to replace the DNA of an embryonic stem cell with DNA from one of the patient's own cells, eliminating the problem of immune rejection. In another approach, differentiating small numbers of ESCs into blood cells and injecting them into the patient creates immune tolerance for other cells types derived from the ESCs, thereby reducing the intensity of rejection by the body.

ASCs, on the other hand, are patient derived and do not face the problem of immune rejection. However, for the most part they have not been as versatile as ESCs, exhibiting only those properties specific to their point of origin. For example, brain and hematopoietic stem cells give rise only to neural tissue and blood cells, respectively.

ASCs' presence in several mature tissues, including bone marrow, blood, adipose tissue, and the brain offsets their inability to differentiate into numerous types of tissues. Recent research has also detected rare ASCs that are 'pluripotent' and hence, capable of forming numerous cell types of the body.

Secondly, ASCs may be unsuitable for regeneration of damaged tissues in the case of elderly patients or due t
'"/>

Contact: Julia Paulson
jpaulson@frost.com
210--247-3870
Technical Insights
15-Jun-2004


Page: 1 2

Related biology news :

1. MSU group reviews Berkeley venture into brave new science funding world
2. Birds eye views earths magnetic lines
3. Digital X-ray microtomography yields stunning views of limb regeneration
4. New views of tropical thunderstorms and pollution effects on rainfall presented at AGU meeting
5. New MRI technology provides detailed views of brain development, response to injury
6. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
7. Sequential signals choreograph embryonic tubule formation
8. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
9. MIT technology jump-starts human embryonic stem cell work
10. New human embryonic stem-cell lines to be made available to researchers
11. Human embryonic stem cells may promise medical advances

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... Va. (PRWEB) , ... November 13, 2019 , ... ... today that Robert Peterson, RAC , a regulatory affairs and program management ... the biopharmaceutical and medical device industries, has joined the firm as an Expert ...
(Date:11/12/2019)... , ... November 12, 2019 , ... ... of orthopedic medical devices, today announced the creation of a Global Regulatory Affairs ... the Medical Device industry is that the regulatory element to any Medtech organization ...
(Date:11/12/2019)... ... November 12, 2019 , ... G5, the leader in ... performance up to 25% and reduces cost-per-click by as much as 15%. An ... attribution (MTA) to predict best advertising outcomes and automatically allocate daily ad investments ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... , ... November 12, 2019 , ... ... services, welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, to the ... (FGS) to ultimately provide investigative leads to law enforcement through proven genealogy ...
(Date:11/5/2019)... ... November 04, 2019 , ... Catalent, ... for drugs, biologics, gene therapies, and consumer health products, today announced the ... enhances Catalent’s proven GPEx expression platform through multiple improvements, including utilization of ...
(Date:11/2/2019)... ... October 31, 2019 , ... drug360 graph, a breakthrough knowledge ... drug360 brings tellic’s expertise in biomedical language processing and machine learning to bear ... between genes, diseases, variants, phenotypes, and other biomedical entities. Researchers and analysts ...
(Date:10/29/2019)... , ... October 29, 2019 , ... ... of the skin*. Using Silios CMS-C multispectral imagers , researchers identified people ... can replace identification based on retinal imaging, face recognition, fingerprints and vasculature. ...
Breaking Biology Technology:
Cached News: